R., Fuse, K., Hahn, G., Schunkert, H., & Wang, S
The use of IGF-1 as a marker becomes even more important if the GH receptor antagonist pegvisomant is used as a treatment as this form of therapy means that circulating levels of GH are no longer suitable to monitor the status of the disease [46,47]
By providing a comprehensive understanding of blockbuster drug strategy in the contemporary pharmaceutical landscape, these goals together seek to close the gap between clinical outcomes and commercial success
That is why certain life stages are associated with symptoms of decreased mental clarity and less emotional stability
A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database